Abu Dhabi, May 19
Basel Ziyadeh, CEO of Gulf Pharmaceutical Industries (Julphar), affirmed that the company continues to strengthen its position as a key driver of the pharmaceutical industry in the UAE.
He noted that Julphar exports more than 80 per cent of its production to around 40 global markets, an achievement that reflects the advancement of its manufacturing infrastructure and the efficiency of national talent.
In statements to the Emirates News Agency (WAM) on the sidelines of the first day of the "Make it in the Emirates 2025", Ziyadeh revealed an ambitious investment plan worth AED 300 million over the next five years. The plan aims to expand the manufacturing base and localise advanced technologies in cooperation with global partners, thereby supporting the national economy by boosting non-oil pharmaceutical exports.
He explained that the company has invested about AED 100 million over the past three years to enhance its manufacturing infrastructure and introduce new technologies. During the same period, it launched more than 35 new pharmaceutical products, meeting the needs of the local market and exporting to various countries.
He stated that after more than 45 years since Julphar's establishment, the company proudly stands as one of the first pharmaceutical firms to launch from the UAE to the world, at a time when the Arab pharmaceutical industry was almost non-existent. Today, the company exports from the UAE to dozens of global markets, relying on one of the largest industrial bases in the Arab region. (ANI/WAM)
— ANI
Reader Comments
Great to see UAE's pharma sector growing! India should take notes on how they're focusing on non-oil exports. Our pharma companies are strong but we need more global partnerships like Julphar is doing. 🇮🇳ðŸ¤ðŸ‡¦ðŸ‡ª
Impressive growth story! But I hope they consider expanding to South Asian markets too. Affordable medicines from UAE could really help countries like Nepal and Bangladesh where healthcare access is limited.
300 million AED investment is no small amount! UAE's vision to diversify beyond oil is working well. Indian pharma companies should explore joint ventures - we have the R&D expertise, they have the infrastructure.
While this is good news, I hope they maintain quality standards. We've seen cases where rapid expansion leads to compromised quality in medicines. Patient safety should remain top priority.
UAE becoming pharma hub is great for Gulf region! But India still leads in affordable generics. Maybe we can collaborate - their investment + our cost-effective production = win-win for developing nations! 💊
Interesting development. I wonder if this will create more job opportunities for Indian pharma professionals in UAE. Many of our graduates look for international exposure, and Gulf countries are preferred destinations.
We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.